X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-01-17 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $1.47 | +150,000 | 246,882,605 | 0% | +$220,425 | ||||||
| M | 2025-01-16 | MKZR | Mackenzie Realty Capital, Inc. | Dixon Robert E | CEO, Pres | P - Purchase | $2.67 | +25,000 | 34,935 | +252% | +$66,750 | |||||
| AM | 2025-01-15 | AVIR | Atea Pharmaceuticals, Inc. | Berger Franklin M | Dir | P - Purchase | $3.26 | +25,000 | 476,897 | +6% | +$81,499 | |||||
2025-01-17 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $2.57 | +10,000 | 922,334 | +1% | +$25,700 | ||||||
2025-01-16 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.84 | +47,904 | 4,135,631 | +1% | +$40,000 | ||||||
| M | 2025-01-15 | AVIR | Atea Pharmaceuticals, Inc. | Berger Franklin M | Dir | P - Purchase | $3.26 | +25,000 | 476,897 | +6% | +$81,499 | |||||
| M | 2024-12-27 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | CEO, 10% | P - Purchase | $0.20 | +787,500 | 122,680,127 | +1% | +$155,757 | |||||
2025-01-15 | VYNE | Vyne Therapeutics Inc. | Lepore Patrick G | Dir | P - Purchase | $2.92 | +15,000 | 51,472 | +41% | +$43,800 | ||||||
| AD | 2024-10-21 | MTBLY | Moatable, Inc. | Oasis Management Co Ltd. | 10% | P - Purchase | $0.84 | +59,168 | 2,662,560 | +2% | +$49,701 | |||||
2025-01-15 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.80 | +62,500 | 4,087,727 | +2% | +$50,000 | ||||||
2025-01-14 | JOB | Gee Group Inc. | Waterfield John Randall | Dir | P - Purchase | $0.24 | +131,779 | 936,779 | +16% | +$31,522 | ||||||
| D | 2025-01-13 | GRYP | Gryphon Digital Mining, Inc. | Kaiser Brittany | Dir | P - Purchase | $0.39 | +96,824 | 965,485 | +11% | +$37,761 | |||||
2025-01-15 | OPK | Opko Health, Inc. | Frost Phillip Md Et Al | CEO, COB, 10% | P - Purchase | $1.48 | +500,000 | 246,732,605 | 0% | +$740,850 | ||||||
| M | 2025-01-13 | OCX | Oncocyte Corp | Smith Patrick W | 10% | P - Purchase | $2.12 | +16,055 | 1,789,958 | +1% | +$34,114 | |||||
| D | 2025-01-13 | GRYP | Gryphon Digital Mining, Inc. | Cox Heather | Dir | P - Purchase | $0.39 | +96,824 | 445,113 | +28% | +$37,761 | |||||
| D | 2025-01-13 | GRYP | Gryphon Digital Mining, Inc. | Gallie Peter Eric | SVP | P - Purchase | $0.39 | +145,236 | 645,236 | +29% | +$56,642 | |||||
| D | 2025-01-13 | GRYP | Gryphon Digital Mining, Inc. | Tolhurst Daniel George | Dir | P - Purchase | $0.39 | +96,824 | 3,670,553 | +3% | +$37,761 | |||||
| D | 2025-01-13 | GRYP | Gryphon Digital Mining, Inc. | Gutterman Steven D. | CEO | P - Purchase | $0.39 | +77,459 | 1,819,315 | +4% | +$30,209 | |||||
2025-01-15 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | P - Purchase | $2.23 | +43,000 | 559,925 | +8% | +$95,890 | ||||||
2025-01-14 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.69 | +87,247 | 4,025,227 | +2% | +$60,000 | ||||||
| M | 2025-01-10 | GBIO | Generation Bio Co. | Quinn Anthony G. | Dir | P - Purchase | $0.96 | +210,791 | 299,286 | +238% | +$203,209 | |||||
| M | 2025-01-13 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.69 | +77,500 | 8,444,000 | +1% | +$130,880 | |||||
2025-01-10 | NRIS | Norris Industries, Inc. | Norris Patrick L. | COB, CEO, CFO, 10% | P - Purchase | $0.08 | +17,362,675 | 47,282,675 | +58% | +$1,389,014 | ||||||
2025-01-13 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.61 | +163,666 | 3,937,980 | +4% | +$100,000 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Duran Felipe | CFO | P - Purchase | $2.72 | +9,191 | 11,139 | +472% | +$25,000 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Brenner Martin | See Remarks | P - Purchase | $2.72 | +9,191 | 18,316 | +101% | +$25,000 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Banjak Marc | GC | P - Purchase | $2.72 | +9,191 | 11,066 | +490% | +$25,000 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Arkowitz David | Dir | P - Purchase | $2.72 | +18,382 | 18,382 | New | +$49,999 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Parada Antonio Bernardino Guimaraes | Dir | P - Purchase | $2.72 | +183,823 | 183,823 | New | +$499,999 | ||||||
2025-01-10 | IBIO | Ibio, Inc. | Sender Gary | Dir | P - Purchase | $2.72 | +9,191 | 9,191 | New | +$25,000 | ||||||
| D | 2025-01-10 | LBSR | Liberty Star Uranium & Metals Corp. | Madaris Patricia | CFO, VP Finance, Acting CEO | P - Purchase | $0.11 | +1,133,574 | 1,133,574 | New | +$124,693 | |||||
2025-01-10 | TBTC | Table Trac Inc | Berger Andrew | Dir | P - Purchase | $3.95 | +27,000 | 27,000 | New | +$106,650 | ||||||
2025-01-09 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir | P - Purchase | $1.37 | +1,457,726 | 1,457,726 | New | +$2,000,000 | ||||||
2025-01-07 | PETS | Petmed Express Inc | Nina Capital Holdings Inc. | 10% | P - Purchase | $4.98 | +25,000 | 2,175,000 | +1% | +$124,375 | ||||||
2025-01-07 | AMST | Amesite Inc. | Parmer George | Dir | P - Purchase | $3.00 | +83,333 | 189,166 | +79% | +$249,999 | ||||||
2025-01-07 | AMST | Amesite Inc. | Sastry Ann Marie | CEO | P - Purchase | $3.00 | +333,333 | 875,431 | +61% | +$999,999 | ||||||
| D | 2025-01-06 | ACXP | Acurx Pharmaceuticals, Inc. | Scodari Joseph C | Dir | P - Purchase | $1.02 | +24,631 | 27,708 | +800% | +$25,000 | |||||
| D | 2025-01-06 | ACXP | Acurx Pharmaceuticals, Inc. | Sailer Carl | Dir | P - Purchase | $1.02 | +24,631 | 142,183 | +21% | +$25,000 | |||||
| D | 2025-01-06 | ACXP | Acurx Pharmaceuticals, Inc. | Luci David P | Pres, CEO, 10% | P - Purchase | $1.02 | +49,261 | 1,147,541 | +4% | +$50,000 | |||||
| D | 2025-01-06 | ACXP | Acurx Pharmaceuticals, Inc. | Deluccia Robert J | Dir, 10% | P - Purchase | $1.02 | +49,261 | 1,014,043 | +5% | +$50,000 | |||||
| M | 2025-01-03 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.70 | +157,800 | 8,358,000 | +2% | +$268,607 | |||||
2024-12-23 | KFFB | Kentucky First Federal Bancorp | Johnson William H | Dir | P - Purchase | $2.98 | +10,000 | 60,889 | +20% | +$29,800 | ||||||
| A | 2025-01-03 | CIK | Credit Suisse Asset Management Income Fund, Inc. | Gerber Charles | Dir | P - Purchase | $2.90 | +8,620 | 8,620 | New | +$25,002 | |||||
| D | 2024-12-24 | ZCAR | Zoomcar Holdings, Inc. | Nishijima Hiroshi | Acting CEO | P - Purchase | $1.56 | +32,052 | 32,052 | New | +$50,001 | |||||
2024-12-31 | WHLM | Wilhelmina International, Inc. | Lichtenstein Warren G | See Explanation of Responses, 10% | P - Purchase | $3.55 | +333,444 | 983,773 | +51% | +$1,182,159 | ||||||
2024-12-31 | SSII | Ss Innovations International, Inc. | Moll Frederic H | Dir | P - Purchase | $1.37 | +2,186,589 | 6,415,589 | +52% | +$3,000,000 | ||||||
2024-12-31 | SOWG | Sow Good Inc. | Goldfarb IRA | Exec COB, 10% | P - Purchase | $2.05 | +12,374 | 6,173,881 | 0% | +$25,367 | ||||||
2024-12-31 | SOWG | Sow Good Inc. | Goldfarb Claudia | CEO, 10% | P - Purchase | $2.05 | +12,374 | 2,169,337 | +1% | +$25,367 | ||||||
2024-12-31 | ACUT | Accustem Sciences Inc. | Cerrone Gabriele M | Dir, 10% | P - Purchase | $0.38 | +100,000 | 4,719,957 | +2% | +$38,100 | ||||||
2024-12-31 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | P - Purchase | $3.07 | +81,433 | 102,344 | +389% | +$249,999 | ||||||
2024-12-31 | OMEX | Odyssey Marine Exploration Inc | Justh Mark B | Dir | P - Purchase | $0.64 | +50,000 | 551,958 | +10% | +$32,235 | ||||||
| D | 2024-12-30 | GRTX | Galera Therapeutics, Inc. | Chang Nancy T | Dir, 10% | P - Purchase | $0.07 | +7,644,932 | 7,644,932 | New | +$499,979 | |||||
| M | 2024-12-30 | CDXS | Codexis, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $4.69 | +45,000 | 8,590,000 | +1% | +$210,995 | |||||
2024-12-27 | PASG | Passage Bio, Inc. | Lynx1 Capital Management LP | 10% | P - Purchase | $0.65 | +373,645 | 9,256,953 | +4% | +$241,038 | ||||||
| M | 2024-12-27 | WHLM | Wilhelmina International, Inc. | Lichtenstein Warren G | See Explanation of Responses, 10% | P - Purchase | $3.08 | +38,051 | 650,329 | +6% | +$117,361 | |||||
2024-12-26 | MINM | Minim, Inc. | Lazar David E. | Dir, 10% | P - Purchase | $0.03 | +1,456,980 | 1,481,980 | >999% | +$49,974 | ||||||
| D | 2024-12-19 | JETMF | Global Crossing Airlines Group Inc. | Jamroz Krzysztof W. | Dir | P - Purchase | $0.46 | +1,162,500 | 1,162,500 | New | +$534,750 | |||||
2024-12-26 | IRD | Opus Genetics, Inc. | Magrath George | CEO | P - Purchase | $0.98 | +100,000 | 599,150 | +20% | +$97,600 | ||||||
2024-12-26 | QIPT | Quipt Home Medical Corp. | Gamble Patrick Dennis | EVP Operations | P - Purchase | $2.45 | +17,000 | 40,057 | +74% | +$41,634 | ||||||
2024-12-23 | FPAY | Flexshopper, Inc. | Heiser Harold Russell Jr. | CEO | P - Purchase | $1.45 | +30,000 | 969,874 | +3% | +$43,500 | ||||||
| M | 2024-12-26 | FPAY | Flexshopper, Inc. | Dvorkin Howard | Dir, 10% | P - Purchase | $1.50 | +20,000 | 4,561,458 | 0% | +$30,000 | |||||
| M | 2024-12-26 | GSAT | Globalstar, Inc. | Monroe James III | Dir, 10% | P - Purchase | $2.12 | +1,500,000 | 1,103,945,953 | 0% | +$3,177,250 | |||||
2024-12-26 | OCX | Oncocyte Corp | Smith Patrick W | 10% | P - Purchase | $2.13 | +90,219 | 1,773,903 | +5% | +$192,166 | ||||||
| D | 2024-12-23 | QNRX | Quoin Pharmaceuticals, Ltd. | Carter Denise P. | COO | P - Purchase | $0.45 | +555,556 | 602,648 | >999% | +$250,000 | |||||
| D | 2024-12-23 | QNRX | Quoin Pharmaceuticals, Ltd. | Myers Michael | CEO | P - Purchase | $0.45 | +555,556 | 602,808 | >999% | +$250,000 | |||||
| D | 2024-12-23 | QNRX | Quoin Pharmaceuticals, Ltd. | Dunn Gordon | CFO | P - Purchase | $0.45 | +122,221 | 151,077 | +424% | +$54,999 | |||||
| D | 2024-12-23 | QNRX | Quoin Pharmaceuticals, Ltd. | Culverwell Anthony James | Dir | P - Purchase | $0.45 | +100,000 | 100,317 | >999% | +$45,000 | |||||
2024-12-24 | PSEC | Prospect Capital Corp | Barry John F | CEO, 10% | P - Purchase | $4.29 | +2,000,000 | 79,809,610 | +3% | +$8,580,000 | ||||||
2024-12-23 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $1.85 | +15,000 | 8,200,000 | 0% | +$27,750 | ||||||
| D | 2024-12-20 | FATE | Fate Therapeutics Inc | Redmile Group, LLC | Dir, 10% | P - Purchase | $1.68 | +397,964 | 12,884,277 | +3% | +$668,580 | |||||
2024-12-23 | VTYX | Ventyx Biosciences, Inc. | Gujrathi Sheila | Dir | P - Purchase | $2.31 | +130,000 | 130,000 | New | +$300,573 | ||||||
2024-12-23 | SRFM | Surf Air Mobility Inc. | Albert Carl A | Dir | P - Purchase | $3.47 | +14,500 | 76,894 | +23% | +$50,315 | ||||||
2024-12-23 | SRFM | Surf Air Mobility Inc. | Shahani Sudhin | Dir | P - Purchase | $3.43 | +17,237 | 360,877 | +5% | +$59,123 | ||||||
2024-12-26 | OCX | Oncocyte Corp | Arno Andrew | Dir | P - Purchase | $2.11 | +12,500 | 97,162 | +15% | +$26,350 | ||||||
2024-12-20 | COSM | Cosmos Health Inc. | Terzis Georgios | CFO | P - Purchase | $0.58 | +85,778 | 727,263 | +13% | +$50,000 | ||||||
2024-12-20 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.58 | +257,334 | 3,774,314 | +7% | +$150,000 | ||||||
2024-12-24 | HWH | Hwh International Inc. | Chan Heng Fai Ambrose | Dir, 10% | P - Purchase | $0.45 | +1,300,000 | 12,687,954 | +11% | +$585,000 | ||||||
| M | 2024-12-20 | IMMX | Immix Biopharma, Inc. | Hsu Jason | Dir | P - Purchase | $2.19 | +47,700 | 4,858,913 | +1% | +$104,358 | |||||
2024-12-23 | ANEB | Anebulo Pharmaceuticals, Inc. | English Aron R. | Dir, 10% | P - Purchase | $0.99 | +10,101,010 | 20,121,828 | +101% | +$10,000,000 | ||||||
2024-12-24 | OMEX | Odyssey Marine Exploration Inc | Justh Mark B | Dir | P - Purchase | $0.55 | +250,000 | 501,958 | +99% | +$137,500 | ||||||
2024-12-23 | MRKR | Marker Therapeutics, Inc. | Elms Steve | Dir | P - Purchase | $3.20 | +11,085 | 328,338 | +3% | +$35,472 | ||||||
| D | 2024-12-13 | SPGC | Sacks Parente Golf, Inc. | Hoge Brett Widney | Dir | P - Purchase | $1.20 | +25,000 | 211,014 | +13% | +$30,000 | |||||
| M | 2024-12-23 | GSAT | Globalstar, Inc. | Monroe James III | Dir, 10% | P - Purchase | $1.94 | +1,000,000 | 1,102,445,953 | 0% | +$1,943,750 | |||||
2024-12-23 | IOBT | Io Biotech, Inc. | Ahmad Qasim Iftikhar | Chief Medical Officer | P - Purchase | $0.85 | +31,350 | 31,350 | New | +$26,553 | ||||||
| M | 2024-12-20 | PRLD | Prelude Therapeutics Inc | Combs Andrew | Chief Chemistry Officer | P - Purchase | $1.36 | +63,075 | 377,623 | +20% | +$85,538 | |||||
2024-12-19 | NOTV | Inotiv, Inc. | Landman David | Dir | P - Purchase | $4.25 | +23,529 | 176,851 | +15% | +$99,998 | ||||||
| EM | 2024-12-18 | CNTM | Connectm Technology Solutions, Inc. | Choudhury Mahesh | See Remarks | P - Purchase | $1.04 | +39,000 | 259,768 | +18% | +$40,413 | |||||
2024-12-19 | RMBL | Rumbleon, Inc. | Cohen Mark Alexander | Member of 10% Group | P - Purchase | $4.18 | +349,333 | 7,104,346 | +5% | +$1,460,212 | ||||||
2024-12-19 | ARDX | Ardelyx, Inc. | Mott David M | Dir | P - Purchase | $4.67 | +213,300 | 1,638,765 | +15% | +$996,580 | ||||||
2024-12-23 | MRKR | Marker Therapeutics, Inc. | New Enterprise Associates 16, L.P. | 10% | P - Purchase | $3.20 | +554,250 | 1,625,678 | +52% | +$1,773,600 | ||||||
2024-12-23 | WWR | Westwater Resources, Inc. | Cryan Terence James | Dir | P - Purchase | $0.54 | +50,000 | 446,443 | +13% | +$27,068 | ||||||
2024-12-20 | MGLD | Marygold Companies, Inc. | Nicholas & Melinda Gerber Living Trust | CEO, 10% | P - Purchase | $1.72 | +42,149 | 18,510,915 | 0% | +$72,538 | ||||||
2024-12-20 | GSAT | Globalstar, Inc. | Monroe James III | Dir, 10% | P - Purchase | $1.97 | +500,000 | 1,101,445,953 | 0% | +$985,050 | ||||||
| AD | 2024-11-08 | NUKK | Nukkleus Inc. | Kotaieva Anastasiia | CEO | P - Purchase | $2.41 | +319,952 | 469,952 | +213% | +$771,084 | |||||
| A | 2024-12-13 | SENS | Senseonics Holdings, Inc. | Roeder Douglas A | Dir | P - Purchase | $0.50 | +75,000 | 1,463,087 | +5% | +$37,500 | |||||
| M | 2024-12-18 | SOL | Emeren Group Ltd | Shah Capital Management | COB, 10% | P - Purchase | $1.77 | +16,853 | 18,818,236 | 0% | +$29,786 | |||||
| D | 2024-11-08 | NUKK | Nukkleus Inc. | Kotaieva Anastasiia | CEO | P - Purchase | $2.41 | +319,952 | 819,952 | +64% | +$771,084 | |||||
2024-12-19 | GSAT | Globalstar, Inc. | Monroe James III | Dir, 10% | P - Purchase | $1.89 | +500,000 | 1,100,945,953 | 0% | +$943,700 | ||||||
| M | 2024-12-18 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO | P - Purchase | $0.93 | +106,888 | 2,822,043 | +4% | +$99,326 | |||||
2024-12-19 | NVNO | Envveno Medical Corp | Berman Robert Andrew | CEO | P - Purchase | $2.55 | +12,000 | 222,236 | +6% | +$30,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |